Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?
Pediatric Blood & Cancer · 2024-08 · 71 (8)
DOI: 10.1002/pbc.31035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 16.05.2024. Verfasst von Gian Luca Forni und 6 weiteren Autor:innen. Beteiligte Einrichtung: ForAnemia Foundation, Genoa, Italy. Hauptthemen laut MEDLINE: beta-Thalassemia, Iron Chelating Agents, Iron Overload, Chelation Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Pharmacosmos.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
In this review, we provide a summary of evidence on iron overload in young children with transfusion‐dependent β‐thalassemia (TDT) and explore the ideal timing for intervention. Key data from clinical trials and observational studies of the three available iron chelators deferoxamine, deferiprone, and deferasirox are also evaluated for inclusion of subsets of young children, especially those less than 6 years of age. Evidence on the efficacy and safety of iron chelation therapy for children ≥2 years of age with transfusional iron overload is widely available. New data exploring the risks and benefits of early‐start iron chelation in younger patients with minimal iron overload are also emerging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ForAnemia Foundation, Genoa, Italy.
- First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
- Division of Hematology, University of Toronto, Toronto, Ontario, Canada.
- Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.
- Division of Hematology and Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
- Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
ORCID-Profile: Gian Luca Forni, Kevin H M Kuo, Ali T Taher, Vip Viprakasit
Förderung
- Pharmacosmos
Zitieren
APA
Forni, G. L., Kattamis, A., Kuo, K. H. M., Maggio, A., Sheth, S., Taher, A. T., & Viprakasit, V. (2024). Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?. Pediatric Blood & Cancer, 71(8). https://doi.org/10.1002/pbc.31035
Vancouver
Forni GL, Kattamis A, Kuo KHM, Maggio A, Sheth S, Taher AT, et al. Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?. Pediatric Blood & Cancer. 2024;71(8). doi:10.1002/pbc.31035
BibTeX
@article{Forni2024,
author = {Forni, Gian Luca and Kattamis, Antonis and Kuo, Kevin H M and Maggio, Aurelio and Sheth, Sujit and Taher, Ali T and Viprakasit, Vip},
title = {Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?},
journal = {Pediatric Blood & Cancer},
year = {2024},
volume = {71},
number = {8},
doi = {10.1002/pbc.31035}
}
EUVIMED